Compare MTX & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTX | HAE |
|---|---|---|
| Founded | 1968 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.6B |
| IPO Year | 2004 | 1996 |
| Metric | MTX | HAE |
|---|---|---|
| Price | $73.12 | $57.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $81.33 | ★ $85.38 |
| AVG Volume (30 Days) | 171.5K | ★ 587.3K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | N/A | ★ 44.54 |
| EPS | N/A | ★ 2.46 |
| Revenue | ★ $2,072,600,000.00 | $910,373,000.00 |
| Revenue This Year | $5.66 | N/A |
| Revenue Next Year | $4.47 | $5.23 |
| P/E Ratio | ★ N/A | $23.79 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $49.54 | $47.32 |
| 52 Week High | $75.30 | $87.32 |
| Indicator | MTX | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 60.70 | 42.16 |
| Support Level | $64.99 | $55.95 |
| Resistance Level | $75.30 | $66.86 |
| Average True Range (ATR) | 1.83 | 1.81 |
| MACD | 0.43 | 0.44 |
| Stochastic Oscillator | 90.35 | 44.58 |
Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.